New Genotype-guided Treatment in Newly Diagnosed PTCL

Clinical trial NCT07706959 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07706959
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Peripheral T-cell Lymphoma (PTCL)

Start date: 2026-07-01
Primary completion: 2028-01-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.